Managing Director of Disease Control Technologies, Andy Butenhoff, recently attended the Bill and Melinda Gates Foundation Innovation to Impact (I2I) Stakeholder Convening in Seattle, Washington. It was an impactful meeting confirming the commitment of all involved to eradicate malaria through vector control.
Gates Foundation has recently committed $500 million to tackle the burden of infections disease in developing countries. “We must remain committed to the eradication of malaria,” Gates said. “Small steps won’t get the job done. History shows that the only way to stop malaria is to end it forever.” He emphasized, however, that long-range efforts to achieve eradication must not distract donors and endemic countries from the immediate objective of “saving lives now.”
DCT is committed to saving lives and stamping out malaria. "We are excited to be a stakeholder in this Gates Foundation initiative," says Butenhoff. "Over coming months, we will work hand and hand with others to shift from alignment to action in multiple I2I touchpoint areas."
Learn more about the Gates Foundation malaria strategy, Accelerate to zero, at http://www.gatesfoundation.org/What-We-Do/Global-Health/Malaria.